[8-K] Superior Industries International, Inc. Reports Material Event

Rhea-AI Filing Summary

Superior Industries International has received a notice from the NYSE on June 17, 2025, regarding non-compliance with continued listing standards due to its stock price falling below $1.00 per share over a 30-trading day period.

The company has a six-month cure period to regain compliance, during which it must achieve: (1) a closing price of at least $1.00 per share on the last trading day of any calendar month, and (2) an average closing price of $1.00 over the 30 trading-day period ending on that day. Trading will continue on NYSE during this period, subject to other listing requirements.

Key impacts if delisting occurs include:

• Reduced trading liquidity and market price
• Lower investor and analyst interest
• Impaired ability to raise capital
• Challenges in employee retention through equity compensation

The company's business operations and SEC reporting requirements remain unaffected by this non-compliance notice.

Positive

• Company has six months cure period to regain NYSE compliance, with possibility of extension
• Current operations and SEC reporting requirements remain unaffected by the NYSE notice

Negative

• NYSE delisting risk: Company received notice for non-compliance as stock price remained below $1.00 for 30 consecutive trading days
• If delisting occurs, company warns of reduced trading liquidity, lower stock demand, adverse publicity, and impaired ability to raise capital
• Potential negative impact on employee retention due to reduced effectiveness of equity compensation if delisting occurs

SUPERIOR INDUSTRIES INTERNATIONAL INC false 0000095552 0000095552 2025-06-17 2025-06-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 17, 2025

SUPERIOR INDUSTRIES INTERNATIONAL, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware		001-06615		95-2594729
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

26600 Telegraph Road, Suite 400 Southfield, Michigan		48033
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (248) 352-7300

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol		Name of Each Exchange on Which Registered
Common Stock, par value $0.01 per share		SUP		New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On June 17, 2025, Superior Industries International, Inc. (“Superior” or the “Company”) received a written notice from the New York Stock Exchange (the “NYSE”) that the Company no longer satisfies the continued listing compliance standards set forth under Section 802.01C of the NYSE Listed Company Manual (the “Manual”) because the average closing price of the Company’s common stock, par value $0.01 per share (the “Common Stock”) was less than $1.00 per share over a consecutive 30-trading day period (the “Share Price Deficiency Notice”).

Pursuant to Section 802.01C of the Manual, the Company has a period of six months following receipt of the Share Price Deficiency Notice to regain compliance with the minimum share price requirement, with the possibility of extension at the discretion of the NYSE. In order to regain compliance, on the last trading day in any calendar month during the cure period, the Common Stock must have: (i) a closing price of at least $1.00 per share; and (ii) an average closing price of at least $1.00 per share over the 30 trading-day period ending on the last trading day of such month. Pursuant to NYSE rules, the Common Stock will continue to be listed and traded on NYSE during these periods, subject to the Company’s compliance with other NYSE continued listing requirements.

The Company’s current noncompliance with the standards described above does not affect the Company’s ongoing business operations or its reporting requirements with the U.S. Securities and Exchange Commission (the “SEC”).

No assurance can be given that the Company will be able to regain compliance with the NYSE requirements or maintain compliance with the other continued listing requirements in the Manual. If the Common Stock ultimately were to be suspended from trading and delisted for any reason, it could have adverse consequences including, among other things, reduced trading liquidity of the Common Stock, lower demand and market price for shares of the Common Stock, adverse publicity and a reduced interest in the Company from investors, analysts and other market participants. In addition, a suspension or delisting could impair the Company’s ability to raise additional capital through the public markets and the Company’s ability to attract and retain employees by means of equity compensation.

Item 7.01 Regulation FD Disclosure.

On June 24, 2025, the Company issued a press release announcing receipt of the Share Price Deficiency Notice. The press release is furnished as Exhibit 99.1 hereto.

The information, including Exhibit 99.1 hereto, which the Company furnished under Item 7.01 of this report is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Registration statements or other documents filed with the SEC shall not incorporate this information by reference, except as otherwise expressly stated in such filing.

Forward Looking- Statements

This Current Report on Form 8-K contains statements that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and can generally be identified by the use of future dates or words such as “assumes,” “may,” “should,” “could,” “will,” “expects,” “expected,” “seeks to,” “anticipates,” “plans,” “believes,” “estimates,” “foresee,” “intends,” “guidance,” “predicts,” “projects,” “projecting,” “potential,” “targeting,” “will likely result,” or “continue,” or the negative of such terms and other comparable terminology. These forward-looking statements involve a number of risks and uncertainties, some of which are beyond Superior’s control, including, without limitation, future fluctuations in the Company’s market capitalization and stockholders’ equity; its ability to submit a required business plan and regain compliance with the Manual and maintain a listing of the Common Stock on NYSE. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, risks, and uncertainties discussed in Superior’s SEC filings and reports.

New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect Superior. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events and/or otherwise, except as may be required by law.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:

Exhibit Number		Exhibit Description
99.1		Press Release of the Company, dated June 24, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						SUPERIOR INDUSTRIES INTERNATIONAL, INC. (Registrant)
Date: June 24, 2025						/s/ David M. Sherbin
						David M. Sherbin
						Senior Vice President, General Counsel, Secretary and Chief Compliance Officer

FAQ

Why did SUP receive a delisting notice from NYSE in June 2025?

Superior Industries (SUP) received a delisting notice from NYSE on June 17, 2025, because its average closing stock price fell below $1.00 per share over a consecutive 30-trading day period, violating Section 802.01C of the NYSE Listed Company Manual.

How long does SUP have to regain NYSE compliance after the June 2025 notice?

SUP has a six-month cure period following receipt of the Share Price Deficiency Notice to regain compliance. To comply, the stock must have a closing price of at least $1.00 per share and an average closing price of at least $1.00 over a 30-trading day period on the last trading day of any calendar month during the cure period.

Will SUP stock continue trading on NYSE during the compliance period?

Yes, SUP's common stock will continue to be listed and traded on NYSE during the compliance period, subject to the company's compliance with other NYSE continued listing requirements. The non-compliance does not affect SUP's business operations or SEC reporting requirements.

What are the potential consequences if SUP fails to regain NYSE compliance?

If SUP fails to regain compliance, potential consequences include: reduced trading liquidity of the Common Stock, lower demand and market price for shares, adverse publicity, reduced interest from investors and analysts, impaired ability to raise additional capital through public markets, and difficulty attracting and retaining employees through equity compensation.